Annual D&A
$29.30 K
$0.000.00%
December 31, 2023
Summary
- As of March 14, 2025, ENTO annual depreciation & amortization is $29.30 thousand, unchanged on December 31, 2023.
- During the last 3 years, ENTO annual D&A has fallen by -$536.00 thousand (-94.82%).
- ENTO annual D&A is now -97.13% below its all-time high of $1.02 million, reached on December 1, 2019.
Performance
ENTO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1300.00
-$34.00 K-96.32%
September 1, 2024
Summary
- As of March 14, 2025, ENTO quarterly depreciation & amortization is $1300.00, with the most recent change of -$34.00 thousand (-96.32%) on September 1, 2024.
- Over the past year, ENTO quarterly D&A has stayed the same.
- ENTO quarterly D&A is now -99.78% below its all-time high of $578.40 thousand, reached on March 1, 2019.
Performance
ENTO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$56.20 K
-$6000.00-9.65%
September 1, 2024
Summary
- As of March 14, 2025, ENTO TTM depreciation & amortization is $56.20 thousand, with the most recent change of -$6000.00 (-9.65%) on September 1, 2024.
- Over the past year, ENTO TTM D&A has stayed the same.
- ENTO TTM D&A is now -95.20% below its all-time high of $1.17 million, reached on March 1, 2019.
Performance
ENTO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ENTO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | 0.0% | 0.0% |
| 3 y3 years | -94.8% | 0.0% | 0.0% |
| 5 y5 years | -96.3% | -99.1% | -90.3% |
ENTO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.6% | at low | -96.3% | at low | -86.5% | +92.5% |
| 5 y | 5-year | -97.1% | at low | -99.1% | at low | -90.3% | +92.5% |
| alltime | all time | -97.1% | at low | -99.8% | at low | -95.2% | +92.5% |
Entero Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1300.00(-96.3%) | $56.20 K(-9.6%) |
| Jun 2024 | - | $35.30 K(+187.0%) | $62.20 K(+81.9%) |
| Mar 2024 | - | $12.30 K(+68.5%) | $34.20 K(+17.1%) |
| Dec 2023 | $29.30 K(0.0%) | $7300.00(0.0%) | $29.20 K(0.0%) |
| Sep 2023 | - | $7300.00(0.0%) | $29.20 K(0.0%) |
| Jun 2023 | - | $7300.00(0.0%) | $29.20 K(0.0%) |
| Mar 2023 | - | $7300.00(0.0%) | $29.20 K(0.0%) |
| Dec 2022 | $29.30 K(-94.6%) | - | - |
| Dec 2022 | - | $7300.00(0.0%) | $29.20 K(-81.6%) |
| Sep 2022 | - | $7300.00(0.0%) | $159.10 K(-45.2%) |
| Jun 2022 | - | $7300.00(0.0%) | $290.10 K(-30.4%) |
| Mar 2022 | - | $7300.00(-94.7%) | $416.70 K(-23.2%) |
| Dec 2021 | $542.30 K(-4.1%) | $137.20 K(-0.8%) | $542.30 K(-1.1%) |
| Sep 2021 | - | $138.30 K(+3.3%) | $548.20 K(-0.3%) |
| Jun 2021 | - | $133.90 K(+0.8%) | $550.00 K(-1.3%) |
| Mar 2021 | - | $132.90 K(-7.1%) | $557.40 K(-1.4%) |
| Dec 2020 | $565.30 K(-44.6%) | $143.10 K(+2.1%) | $565.30 K(-0.1%) |
| Sep 2020 | - | $140.10 K(-0.8%) | $565.90 K(-1.6%) |
| Jun 2020 | - | $141.30 K(+0.4%) | $574.90 K(-1.3%) |
| Mar 2020 | - | $140.80 K(-2.0%) | $582.40 K(-42.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $1.02 M(+27.8%) | $143.70 K(-3.6%) | $1.02 M(-4.7%) |
| Sep 2019 | - | $149.10 K(+0.2%) | $1.07 M(-4.3%) |
| Jun 2019 | - | $148.80 K(-74.3%) | $1.12 M(-4.5%) |
| Mar 2019 | - | $578.40 K(+198.6%) | $1.17 M(+46.6%) |
| Dec 2018 | $798.40 K(+5.9%) | $193.70 K(-1.6%) | $798.50 K(-0.5%) |
| Sep 2018 | - | $196.90 K(-2.3%) | $802.20 K(+2.5%) |
| Jun 2018 | - | $201.50 K(-2.4%) | $782.90 K(-0.1%) |
| Mar 2018 | - | $206.40 K(+4.6%) | $783.60 K(+3.9%) |
| Dec 2017 | $754.00 K(+2.7%) | $197.40 K(+11.1%) | $754.00 K(+2.5%) |
| Sep 2017 | - | $177.60 K(-12.2%) | $735.70 K(-1.0%) |
| Jun 2017 | - | $202.20 K(+14.4%) | $743.30 K(+2.0%) |
| Mar 2017 | - | $176.80 K(-1.3%) | $728.40 K(-0.8%) |
| Dec 2016 | $734.50 K(+0.1%) | $179.10 K(-3.3%) | $734.40 K(-0.6%) |
| Sep 2016 | - | $185.20 K(-1.1%) | $738.60 K(+0.4%) |
| Jun 2016 | - | $187.30 K(+2.5%) | $735.60 K(+0.7%) |
| Mar 2016 | - | $182.80 K(-0.3%) | $730.20 K(-0.5%) |
| Dec 2015 | $733.60 K | $183.30 K(+0.6%) | $733.60 K(+33.3%) |
| Sep 2015 | - | $182.20 K(+0.2%) | $550.30 K(+49.5%) |
| Jun 2015 | - | $181.90 K(-2.3%) | $368.10 K(+97.7%) |
| Mar 2015 | - | $186.20 K | $186.20 K |
FAQ
- What is Entero Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Entero Therapeutics?
- What is Entero Therapeutics annual D&A year-on-year change?
- What is Entero Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Entero Therapeutics?
- What is Entero Therapeutics quarterly D&A year-on-year change?
- What is Entero Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Entero Therapeutics?
- What is Entero Therapeutics TTM D&A year-on-year change?
What is Entero Therapeutics annual depreciation & amortization?
The current annual D&A of ENTO is $29.30 K
What is the all time high annual D&A for Entero Therapeutics?
Entero Therapeutics all-time high annual depreciation & amortization is $1.02 M
What is Entero Therapeutics annual D&A year-on-year change?
Over the past year, ENTO annual depreciation & amortization has changed by $0.00 (0.00%)
What is Entero Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ENTO is $1300.00
What is the all time high quarterly D&A for Entero Therapeutics?
Entero Therapeutics all-time high quarterly depreciation & amortization is $578.40 K
What is Entero Therapeutics quarterly D&A year-on-year change?
Over the past year, ENTO quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Entero Therapeutics TTM depreciation & amortization?
The current TTM D&A of ENTO is $56.20 K
What is the all time high TTM D&A for Entero Therapeutics?
Entero Therapeutics all-time high TTM depreciation & amortization is $1.17 M
What is Entero Therapeutics TTM D&A year-on-year change?
Over the past year, ENTO TTM depreciation & amortization has changed by $0.00 (0.00%)